Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease
ContributorsHill, Derek L G; Schwarz, Adam J; Isaac, Maria; Pani, Luca; Vamvakas, Spiros; Hemmings, Robert; Carrillo, Maria C; Yu, Peng; Sun, Jia; Beckett, Laurel; Boccardi, Marina; Brewer, James; Brumfield, Martha; Cantillon, Marc; Cole, Patricia E; Fox, Nick; Frisoni, Giovanni; Jack, Clifford; Kelleher, Thomas; Luo, Feng; Novak, Gerald; Maguire, Paul; Meibach, Richard; Patterson, Patricia; Bain, Lisa; Sampaio, Cristina; Raunig, David; Soares, Holly; Suhy, Joyce; Wang, Huanli; Wolz, Robin; Stephenson, Diane
Published inAlzheimer's & dementia, vol. 10, no. 4, p. 421-429.e3
Publication date2014
Abstract
Affiliation entities
Research groups
Citation (ISO format)
HILL, Derek L G et al. Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer’s disease. In: Alzheimer’s & dementia, 2014, vol. 10, n° 4, p. 421–429.e3. doi: 10.1016/j.jalz.2013.07.003
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:44751
- DOI : 10.1016/j.jalz.2013.07.003
- PMID : 24985687
Journal ISSN1552-5260
